Global Clinical Trial Imaging Market Introduction and Overview
According to SPER Market Research, the Global Clinical Trial Imaging Market is estimated to reach USD 2.37 billion by 2033 with a CAGR of 7.83%.
The report includes an in-depth analysis of the Global Clinical Trial Imaging Market, including market size and trends, product mix, distribution channels, and supplier analysis. A clinical trial is a procedure for creating, studying, and assessing the effects of innovative medications. Before the introduction, extensive clinical testing is conducted to find promising molecules and determine any potential dangers. Companies that offer imaging services including image acquisition, analysis, and management are included in the clinical trial imaging market, as are businesses that create and produce imaging hardware and software for clinical trials.
- Strict Regulatory Policies: The healthcare sector is governed by a complex and broad system of laws, rules, and regulations. The quality of imaging data produced in clinical trials is covered by the U.S. FDA's revised Guidance for Clinical Trial Imaging Endpoint Process Standards, which was published for the industry in April 2018.
- Advancements in medical imaging technology: The continuous advancements in medical imaging technology have expanded the capabilities of imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and ultrasound. These advancements allow for more precise and accurate imaging, enabling researchers to obtain detailed images for better analysis and evaluation in clinical trials.
Market Opportunities and Challenges
One important market opportunity for the global clinical trial imaging market is the increasing demand for personalized medicine and targeted therapies. As the understanding of diseases at the molecular level advances, there is a growing need to assess treatment efficacy and patient response using imaging techniques. Clinical trial imaging can play a crucial role in evaluating the effectiveness of targeted therapies by providing insights into drug distribution, target engagement, and treatment response. This presents an opportunity for the clinical trial imaging market to support the development and approval of personalized medicines.
However, a significant challenge in the global clinical trial imaging market is the complexity of integrating imaging data with other types of clinical data. Integrating imaging data with molecular, genomic, and clinical data from various sources requires robust data management and interoperability solutions. The challenge lies in standardizing data formats, developing interoperable systems, and ensuring seamless integration across different platforms and data repositories. Overcoming this challenge is essential for maximizing the potential of clinical trial imaging and harnessing the full power of multi-modal data analysis for improved clinical decision-making and patient outcomes.
Market Competitive Landscape
The Clinical Trial Imaging market is characterized by moderate competition, with multiple players operating in the industry. To maintain market share and diversify their product offerings, these big firms are implementing growth tactics such as new product launches, mergers, and acquisitions. The key players in the global Clinical Trial Imaging market include anagram 4 clinical trials, BioTelemetry (a Philips Company), Calyx, Clario, ICON plc, Image Core Lab, Invicro.LLC, IXICO plc, Koninklijke Philips N.V., Median Technologies, Navitas Life Sciences, Paraxel International Corporation, Perspectum, Quotient Sciences, Radiant Sage LLC, Resonance Health Analytical Services, WIRB-Copernicus Group, WORLDCARE CLINICAL, Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Product & Services, By Modality, By Therapeutic area, By End-User
|
| Regions covered | Asia-Pacific, Europe, Middle East and Africa, North America, Latin America
|
| Companies Covered | anagram 4 clinical trials, BioTelemetry (a Philips Company), Calyx, Clario, ICON plc, Image Core Lab, Invicro.LLC, IXICO plc, Koninklijke Philips N.V., Median Technologies, Navitas Life Sciences, Paraxel International Corporation, Perspectum, Quotient Sciences, Radiant Sage LLC, Resonance Health Analytical Services, WIRB-Copernicus Group, WORLDCARE CLINICAL, Others
|
COVID-19 Impact on Global Clinical Trial Imaging Market
The COVID-19 pandemic caused significant disruptions to clinical trials worldwide, leading to a decrease in the number of trials being conducted and impacting the demand for clinical trial imaging services. Lockdowns, travel restrictions, and fear of exposure to the virus resulted in reduced patient enrolment, affecting the availability of participants for imaging studies. Regulatory processes faced delays, causing challenges in obtaining approvals and hindering trial progress. To mitigate the impact, there was an increased focus on remote monitoring, allowing for remote collection and analysis of imaging data, reducing the need for in-person visits and imaging assessments.
Key Target Audience:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutions
- Clinical Research Associates (CRAs) and Investigators
- Regulatory Authorities
- Imaging Core Laboratories
- Imaging Equipment and Software Providers
- Investors and Venture Capital Firms
- Regulatory Consultants and Legal Professionals
- Healthcare Providers
Our in-depth analysis of the Clinical Trial Imaging Market includes the following segments:
|
By Product & Services:
|
Imaging Software
Operational Imaging Services
Project & Data Management Services
Read Analysis Services
System and Technical Support Services
Trial Design & Consulting Services
|
|
By Modality:
|
Computed Tomography
Echocardiography
Magnetic Resonance Imaging
Nuclear Medicine
Optical Coherence Tomography
Positron Emission Tomography
Ultrasound
X-ray
Other Modalities
|
|
By Therapeutic area:
|
Oncology
Infectious Diseases
Neurology
CVS
Endocrinology
Immunological Disorder
Dermatology
Haematology
Gastroenterology
Other Therapeutic Area
|
|
By End-User:
|
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturer
Contract Research Organizations
Other End-Users
|
Key Topics Covered in the Report:
- Global Clinical Trial Imaging Market Size (FY’2023-FY’2033)
- Description of Global Clinical Trial Imaging Market
- Segmentation of Global Clinical Trial Imaging Market By Product & Services (Imaging Software, Operational Imaging Services, Project & Data Management Services, Read Analysis Services, System and Technical Support Services, Trial Design & Consulting Services)
- Segmentation of Global Clinical Trial Imaging Market By Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Nuclear Medicine, Optical Coherence Tomography, Positron Emission Tomography, Ultrasound, X-ray, Other Modalities)
- Segmentation of Global Clinical Trial Imaging Market By Therapeutic area (Oncology, Infectious Diseases, Neurology, CVS, Endocrinology, Immunological Disorder, Dermatology, Haematology, Gastroenterology, Other Therapeutic Area)
- Segmentation of Global Clinical Trial Imaging Market By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Other End-Users)
- Statistical Snap of Global Clinical Trial Imaging Market
- Expansion Analysis of Global Clinical Trial Imaging Market
- Problems and Obstacles in Global Clinical Trial Imaging Market
- Competitive Landscape in the Global Clinical Trial Imaging Market
- Impact of COVID-19 and Demonetization on Global Clinical Trial Imaging Market
- Details on Current Investment in Global Clinical Trial Imaging Market
- Competitive Analysis of Global Clinical Trial Imaging Market
- Prominent Players in the Global Clinical Trial Imaging Market
- SWOT Analysis of Global Clinical Trial Imaging Market
- Global Clinical Trial Imaging Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Clinical Trial Imaging Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Clinical Trial Imaging Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Clinical Trial Imaging Market
7. Global Clinical Trial Imaging Market, By Product & Services (USD Million)
7.1. Global Clinical Trial Imaging Market Value Share and Forecast, By Product & Services, 2023-2033
7.2. Imaging Software
7.3. Operational Imaging Services
7.4. Project & Data Management Services
7.5. Read Analysis Services
7.6. System and Technical Support Services
7.7. Trial Design & Consulting Services
8. Global Clinical Trial Imaging Market, By Modality (USD Million)
8.1. Global Clinical Trial Imaging Market Value Share and Forecast, By Modality, 2023-2033
8.2. Computed Tomography
8.3. Echocardiography
8.4. Magnetic Resonance Imaging
8.5. Nuclear Medicine
8.6. Optical Coherence Tomography
8.7. Positron Emission Tomography
8.8. Ultrasound
8.9. X-ray
8.10. Other Modalities
9. Global Clinical Trial Imaging Market, By Therapeutic area (USD Million)
9.1. Global Clinical Trial Imaging Market Value Share and Forecast, By Therapeutic area, 2023-2033
9.2. Oncology
9.3. Infectious Diseases
9.4. Neurology
9.5. CVS
9.6. Endocrinology
9.7. Immunological Disorder
9.8. Dermatology
9.9. Haematology
9.10. Gastroenterology
9.11. Other Therapeutic Area
10. Global Clinical Trial Imaging Market, By End-User (USD Million)
10.1. Global Clinical Trial Imaging Market Value Share and Forecast, By End-User, 2023-2033
10.2. Pharmaceutical Companies
10.3. Biotechnology Companies
10.4. Medical Device Manufacturer
10.5. Contract Research Organizations
10.6. Other End-Users
11. Global Clinical Trial Imaging Market Forecast, 2019-2033 (USD Million)
11.1. Global Clinical Trial Imaging Market Size and Market Share
12. Global Clinical Trial Imaging Market, By Product & Services, 2019-2033 (USD Million)
12.1. Global Clinical Trial Imaging Market Size and Market Share By Product & Services (2019-2026)
12.2. Global Clinical Trial Imaging Market Size and Market Share By Product & Services (2027-2033)
13. Global Clinical Trial Imaging Market, By Modality, 2019-2033 (USD Million)
13.1. Global Clinical Trial Imaging Market Size and Market Share By Modality (2019-2026)
13.2. Global Clinical Trial Imaging Market Size and Market Share By Modality (2027-2033)
14. Global Clinical Trial Imaging Market, By Therapeutic area, 2019-2033 (USD Million)
14.1. Global Clinical Trial Imaging Market Size and Market Share By Therapeutic area (2019-2026)
14.2. Global Clinical Trial Imaging Market Size and Market Share By Therapeutic area (2027-2033)
15. Global Clinical Trial Imaging Market, By End-User, 2019-2033 (USD Million)
15.1. Global Clinical Trial Imaging Market Size and Market Share By End-User (2019-2026)
15.2. Global Clinical Trial Imaging Market Size and Market Share By End-User (2027-2033)
16. Global Clinical Trial Imaging Market, By Region, 2019-2033 (USD Million)
16.1. Global Clinical Trial Imaging Market Size and Market Share By Region (2019-2026)
16.2. Global Clinical Trial Imaging Market Size and Market Share By Region (2027-2033)
16.3. Asia-Pacific
16.3.1. Australia
16.3.2. China
16.3.3. India
16.3.4. Japan
16.3.5. South Korea
16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France
16.4.2. Germany
16.4.3. Italy
16.4.4. Spain
16.4.5. United Kingdom
16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia
16.5.2. United Arab Emirates
16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada
16.6.2. Mexico
16.6.3. United States
16.7. Latin America
16.7.1. Argentina
16.7.2. Brazil
16.7.3. Rest of Latin America
17. Company Profile
17.1. anagram 4 clinical trials
17.1.1. Company details
17.1.2. Financial outlook
17.1.3. Product summary
17.1.4. Recent developments
17.2. BioTelemetry
17.2.1. Company details
17.2.2. Financial outlook
17.2.3. Product summary
17.2.4. Recent developments
17.3. Calyx
17.3.1. Company details
17.3.2. Financial outlook
17.3.3. Product summary
17.3.4. Recent developments
17.4. Clario
17.4.1. Company details
17.4.2. Financial outlook
17.4.3. Product summary
17.4.4. Recent developments
17.5. ICON plc
17.5.1. Company details
17.5.2. Financial outlook
17.5.3. Product summary
17.5.4. Recent developments
17.6. Image Core Lab
17.6.1. Company details
17.6.2. Financial outlook
17.6.3. Product summary
17.6.4. Recent developments
17.7. Invicro LLC
17.7.1. Company details
17.7.2. Financial outlook
17.7.3. Product summary
17.7.4. Recent developments
17.8. IXICO plc
17.8.1. Company details
17.8.2. Financial outlook
17.8.3. Product summary
17.8.4. Recent developments
17.9. Koninklijke Philips N.V.
17.9.1. Company details
17.9.2. Financial outlook
17.9.3. Product summary
17.9.4. Recent developments
17.10. Median Technologies
17.10.1. Company details
17.10.2. Financial outlook
17.10.3. Product summary
17.10.4. Recent developments
17.11. Navitas Life Sciences
17.11.1. Company details
17.11.2. Financial outlook
17.11.3. Product summary
17.11.4. Recent developments
17.12. Paraxel International Corporation
17.12.1. Company details
17.12.2. Financial outlook
17.12.3. Product summary
17.12.4. Recent developments
17.13. Perspectum
17.13.1. Company details
17.13.2. Financial outlook
17.13.3. Product summary
17.13.4. Recent developments
17.14. Quotient Sciences
17.14.1. Company details
17.14.2. Financial outlook
17.14.3. Product summary
17.14.4. Recent developments
17.15. Radiant Sage LLC
17.15.1. Company details
17.15.2. Financial outlook
17.15.3. Product summary
17.15.4. Recent developments
17.16. Resonance Health Analytical Services
17.16.1. Company details
17.16.2. Financial outlook
17.16.3. Product summary
17.16.4. Recent developments
17.17. WIRB-Copernicus Group
17.17.1. Company details
17.17.2. Financial outlook
17.17.3. Product summary
17.17.4. Recent developments
17.18. WORLDCARE CLINICAL
17.18.1. Company details
17.18.2. Financial outlook
17.18.3. Product summary
17.18.4. Recent developments
17.19. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope